Doi.org/10.1016/j.dld.2014.11.015

Target ArticleEdit

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial; Shihui Chen et al. ; Digestive and Liver Disease; 2014; https://doi.org/10.1016/j.dld.2014.11.015

Article providing commentsEdit

Comment on “Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial” by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226–32]; Rotman, Yaron; ; Digestive and Liver Disease; 2015-12-01 https://doi.org/10.1016/j.dld.2015.08.011

SummaryEdit

Note: Opened to append information.